Molina Healthcare exits S&P 500—what's next for investors?

Molina Healthcare, a major U.S. provider of Medicaid and Medicare managed care, will leave the S&P 500 index on 23 March 2026. The company specialises in serving low-income populations and has recently posted strong financial results despite rising medical costs.

The removal may create short-term challenges for its stock price but could also open opportunities for investors who see the firm as undervalued compared to rivals like UnitedHealth or Humana.

Molina Healthcare's exit from the S&P 500 follows a decision by the index committee. Historically, shares of removed companies have fallen by 5 to 10 percent in the days after the announcement. However, the firm is likely to stay in other indices, such as the S&P MidCap 400 or Russell 2000, which should help maintain liquidity.

The company's business model depends heavily on government-funded healthcare programmes. This exposure leaves it vulnerable to political shifts and regulatory changes in the U.S. healthcare sector. At the same time, Molina benefits from stable demand driven by an ageing population and consistent enrolment in Medicare and Medicaid. Recent financial reports show solid performance, though profit margins have been squeezed by increasing medical expenses. Investors, particularly those in the DACH region, may view Molina as a way to gain exposure to the U.S. healthcare market. Some active traders see the stock as undervalued relative to competitors, potentially making it an attractive buying opportunity. Centene Corporation, another managed care provider with a similar focus on low-income populations, remains in the S&P 500. Both companies operate in the same space, offering Medicaid and Medicare plans, including dual-eligible and special needs programmes.

Molina Healthcare's removal from the S&P 500 brings both risks and potential rewards for shareholders. The stock could face short-term pressure, but the company's stable government contracts and long-term demographic trends may support its financial position.

Investors will now watch how the market reacts and whether the firm's inclusion in smaller indices helps offset any downturn.